Prognostic significance of nephrectomy in metastatic renal cell carcinoma treated with systemic cytokine or targeted therapy: A 16-year retrospective analysis-Reference-Cited by-同舟云学术

Prognostic significance of nephrectomy in metastatic renal cell carcinoma treated with systemic cytokine or targeted therapy: A 16-year retrospective analysis

Published:2018-02-14 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Kim Sung Han,Jeong Kyung-Chae,Joung Jae Young,Seo Ho Kyung^ORCID,Lee Kang Hyun,Chung Jinsoo

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-20822-2.pdf

Reference32 articles.

1. Ljungberg, B. et al. The epidemiology of renal cell carcinoma. Eur Urol. 60, 615–21 (2011).

2. Basso, M., Cassano, A. & Barone, C. A survey of therapy for advanced renal cell carcinoma. Urol Oncol. 28, 121–33 (2010).

3. Hong, X. et al. Prognostic value of cytoreductive nephrectomy combined with targeted therapy for metastatic renal cell carcinoma: a meta-analysis. Int Urol Nephrol. 48, 967–75 (2016).

4. Bex, A., Ljungberg, B., van Poppel, H. & Powles, T. The Role of Cytoreductive Nephrectomy: European Association of Urology Recommendations in 2016. Eur Urol. 70, 901–905 (2016).

5. Culp, S. H. Cytoreductive nephrectomy and its role in the present-day period of targeted therapy. Ther Adv Urol. 7, 275–85 (2015).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Banana-shaped survival curves of metastatic renal cell carcinoma treated with first-line immune-combinations, not just a matter of “palateau”;Human Vaccines & Immunotherapeutics;2024-05-17

2. Survival prognoses of Heng intermediate-risk patients with metastatic renal cell carcinoma treated with immunotherapy or targeted therapy: A real-world, single-center retrospective study;Investigative and Clinical Urology;2020

3. A Retrospective Analysis of the Impact of Metastasectomy on Prognostic Survival According to Metastatic Organs in Patients With Metastatic Renal Cell Carcinoma;Frontiers in Oncology;2019-05-22

4. Circulating and tissue IMP3 levels are correlated with poor survival in renal cell carcinoma;International Journal of Cancer;2019-01-31